The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
evolva | 20 |
inbicon | 16 |
bayer cropscience | 13 |
cancer research technology | 12 |
novo nordisk | 11 |
serodus | 8 |
chr. hansen | 7 |
leo pharma | 7 |
foss analytical | 6 |
phlogo | 6 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
priming of an immune response | 23 | 2008 |
enzymatic hydrolysis of biomasses having a high dry matter (dm) content | 22 | 2004 |
high-affinity, dimeric inhibitors of psd-95 as efficient neuroprotectants against ischem… 🛈 | 21 | 2011 |
masp isoforms as inhibitors of complement activation | 20 | 2009 |
il-4-derived peptides for modulation of the chronic inflammatory response and treatment … 🛈 | 18 | 2008 |
antagonists of the interleukin-1 receptor | 17 | 2011 |
glucosinolate transporter protein and uses thereof | 14 | 2010 |
fatty acid derivatives of dimeric inhibitors of psd-95 | 13 | 2013 |
generation of a cancer-specific immune response toward muc1 and cancer specific muc1 ant… 🛈 | 13 | 2006 |
glycosyltransferase glycosylating flavokermesic acid and/or kermesic acid | 12 | 2013 |